1 study found for:    "RWJMS" OR "Robert Wood Johnson Medical School" OR "Cancer Institute of New Jersey" OR "CINJ" | Open Studies | "Neurologic Manifestations"
Show Display Options
Rank Status Study
1 Recruiting Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Interventions: Drug: BMS-986168;   Drug: Placebo

Indicates status has not been verified in more than two years